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Recently, direct reprogramming between divergent
lineages has been achieved by the introduction of
regulatory transcription factors. This approach may
provide alternative cell resources for drug discovery
and regenerative medicine, but applications could
be limited by the genetic manipulation involved.
Here, we show that mouse fibroblasts can be
directly converted into neuronal cells using only a
cocktail of small molecules, with a yield of up to
>90%being TUJ1-positive after 16 days of induction.
After a further maturation stage, these chemically
induced neurons (CiNs) possessed neuron-specific
expression patterns, generated action potentials,
and formed functional synapses. Mechanistically,
we found that a BET family bromodomain inhibitor,
I-BET151, disrupted the fibroblast-specific program,
while the neurogenesis inducer ISX9 was necessary
to activate neuron-specific genes. Overall, our find-
ings provide a ‘‘proof of principle’’ for chemically
induced direct reprogramming of somatic cell fates
across germ layers without genetic manipulation,
through disruption of cell-specific programs and in-
duction of an alternative fate.
INTRODUCTION
A major question in regenerative medicine is how best to obtain
customized functional cell types. Recently, direct lineage reprog-
ramming has emerged as a promising, fast, and direct approach
for manipulating cell fate that avoids the teratoma risks associ-
ated with pluripotent stem cells. Fibroblasts can be directly con-
verted into diverse functional cell types by the viral introduction of
known cell-fate-determining transcription factors or microRNAs
(Davis et al., 1987; Vierbuchen et al., 2010; Xu et al., 2015; Yoo
et al., 2011). The approach of direct reprogramming has beenCused in disease modeling, suggesting promising applications in
regenerative medicine (Xu et al., 2015). Moreover, direct reprog-
ramming of cell fates in vivo could potentially provide a route to
in situ regeneration for therapeutic purposes (Xu et al., 2015).
However, the low efficiency of induction, the technical chal-
lenges involved, and the genomic integration of the viral vectors
used for direct reprogramming have raised concerns about the
potential for future applications of this approach. An alternative
strategy based on small molecules to induce cell-lineage reprog-
ramming would be advantageous because such a strategy
would be non-immunogenic, cost effective, and easy to manip-
ulate and standardize. In addition, the application of small mole-
cules is reversible and does not require cell permeabilization.
Because of these advantages, such a strategy could potentially
be translated into therapeutic applications (Yu et al., 2014).
Recently, we developed a small-molecule approach to induce
pluripotency from mouse somatic cells without the use of exoge-
nous factors (Hou et al., 2013), demonstrating the feasibility of
chemically reprogramming mouse somatic cell fates toward plu-
ripotency. However, the possibility of direct cell fate conversion
between two differentiated cell types by pure chemicals has not
been examined. In the past, several studies have employed small
molecules to enhance the efficiency of direct reprogramming or
replace part of the reprogramming transcription factor cocktail
required (Ladewigetal., 2012;Liuetal., 2013;Xuetal., 2015).How-
ever, a pure small-molecule approach for direct cell fate reprog-
ramming without genetic manipulation has not been described.
In this study,we identifieda cocktail of smallmolecules capable
of establishing neuronal features in mouse fibroblasts efficiently
and directly. The small molecules disrupt the fibroblast-specific
program, activate the endogenous expression of neuronal-
specific genes, and convert fibroblasts to functional neurons.RESULTS
Small-Molecule Screening for Compounds Inducing
Neuronal Fate
To identify neuronal-fate-inducing small molecules, we started
out with a primary chemical screen. In a previous study, a setell Stem Cell 17, 195–203, August 6, 2015 ª2015 Elsevier Inc. 195
Figure 1. Identification of Neuronal Fate-
Inducing Small Molecules
(A) Diagram of the small-molecule screening for
candidate compounds.
(B and C) Four small molecules were found to
substantially potentiate fibroblast-to-neuron con-
version with Ascl1. (B) Quantification of TUJ1-
positive cells with circular cell bodies and neurite
outgrowth that is at least 3-fold longer than the cell
body. Ten randomly selected visual fields (203)
were used to determine the cell number, and the
graph represents the percentage of the qualified
TUJ1-positive cells relative to DAPI-stained cells.
(C) Representative TUJ1-positive cells induced by
A only and A+SMs.
(D) Diagram of the SM induction process. FM,
fibroblast medium; IM, neuronal induction medium.
(E) Representative TUJ1-positive cells induced
by SMs.
(F) Quantification of TUJ1-positive cells induced
by SMs (ten 203 visual fields were randomly
selected to determine the number relative to
DAPI-stained cells).
A, Ascl1; Control, not induced (NI); S, SB431542;
C, CHIR99021; I, ISX9; F, Forskolin; DMSO,
vehicle control. The data are presented as the
mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001
(Student’s t test). The scale bars represent
100 mm.of three transcription factors (Ascl1, Brn2, and Myt1l) was
shown to induce the generation of neurons from mouse fibro-
blasts, in which Ascl1 is the master gene for inducing neuronal
fate, while Brn2 and Myt1l enhance the neuronal conversion as
the supplementary factors (Vierbuchen et al., 2010). Without
Brn2 and Myt1l, Ascl1 alone induces neurons with low effi-
ciency (Vierbuchen et al., 2010). Accordingly, we first per-
formed a chemical screen for small molecules promoting
Ascl1-based conversion (Figure 1A) (Tucker et al., 2001; Vier-
buchen et al., 2010). By screening about 5,000 small molecules
(Table S1A), we found that Forskolin, ISX9, CHIR99021, and
SB431542 each increased the number of TAUEGFP-/TUJ1-
positive neuronal cells induced by Ascl1 by more than 2-fold
(Figure 1B). In the presence of Ascl1, the combination of these
four chemical boosters further increased the efficiency of
generating induced neurons (iNs) (>10-fold enhancement than
Ascl1 infection alone without compounds) (Figures 1B and
1C). Thus, we identified a combination of four small molecules196 Cell Stem Cell 17, 195–203, August 6, 2015 ª2015 Elsevier Inc.that robustly facilitate Ascl1-mediated
induction of neuronal fates from mouse
fibroblasts.
To examine whether the exogenous
‘‘master genes’’ are dispensable for
inducing neuronal fates, we induced the
starting fibroblasts in a transgene-free
manner (Figure 1D). Interestingly, in the
absence of exogenous Ascl1, culture
medium containing the four small-mole-
cule cocktail ‘‘FICS’’ (Forskolin, ISX9,
CHIR99021, and SB431542) sufficed to
induce neuronal fate over an extendedduration (21 days) with a >30% yield of TUJ1-positive cells
with primitive neuronal-like morphology (Figures 1D and 1F;
Table S1B). Each small molecule alone failed to generate
neuronal-like cells, suggesting that synergy between the small
molecules may be crucial (Figure 1F). These findings suggest
that the small-molecule cocktail can initiate neuronal fates from
fibroblasts.
Identification of I-BET151-Facilitated Chemical
Reprogramming
To improve the transgene-free chemical induction into a more
robust system, we performed another chemical screen for
additional small molecules that facilitate neuronal reprogram-
ming and maturation. We were hoping to find additional small
molecules that could induce neurons with improved neurite
outgrowth and, ideally, complex morphologies (Figure 2A) (Vier-
buchen et al., 2010). By screening about 1,500 small molecules
on ‘‘FICS+1’’ (Figure 2A), we found that an additional small
molecule, I-BET151, dramatically enhanced the reprogramming
rate (with a 90% TUJ1-positive cell yield) and neurite outgrowth
of the iNs (Figure 2B and Table S1B). Moreover, in the revised
cocktail, FICSB, SB431542 (S) was dispensable for generating
neurons, although it enhanced the survival and neurite outgrowth
of the iNs (Figure 2C and Figure S1A). We then used the
small molecule cocktail FICB in further experiments, and the
concentration of each small molecule was further optimized (Fig-
ure S1B). The FICB combination converted fibroblasts into neu-
rons with a yield up to >90% TUJ1-postive cells (in which 71%
were TAUEGFP/TUJ1 double positive and 30% NEUN/TUJ1
double positive) with extensive neurite outgrowth after 16–
20 days of induction (Figures 2B and 2C). The FICB-induced cells
co-expressed multiple neuronal-specific markers, including
MAP2 and NF-H (Figure 2D). Furthermore, the FICB-induced
cells seemed to be heterogeneously excitatory and inhibitory,
based on detection of both VGLUT1- and GABA-positive neu-
rons (Figure 2D). Taken together, these results suggest that
chemical reprogramming into neuronal-like cells has been
achieved by using FICB.
Gene Expression Profiling of CiNs Resembles That of
Functional Neurons
To further promote the maturation of the induced neuronal-like
cells, we used co-culturing of the induced cells with primary as-
trocytes in maturation medium as reported previously (Chanda
et al., 2014; Vierbuchen et al., 2010). After we promoted their
maturation for 14–21 days, the induced cells showed more
extensively extended neurite outgrowth (Figure 2E). These
chemically induced neurons were then referred to as CiNs (Fig-
ure 2F). To verify the co-expression of neuronal and functional
subtype-specific markers and avoid the noise associated with
a mixed cell population, we performed single-cell expression
profiling on the CiNs. Co-expression of multiple pan-neuronal
and functional synaptic markers was confirmed by these sin-
gle-cell experiments (Figure 2G and Figure S1C). Both excitatory
and inhibitory subtypes of single CiNs were detected. Themajor-
ity of the CiNs are the excitatory, glutamatergic neurons (about
45.8%), as indicated by the expression of vGlut, and the percent-
age of the inhibitory subtype is about 20.8%, as indicated by
the expression of Gad67 (Figure S1C). Furthermore, we found
that the induced cells not only established a neuron-specific
transcriptional program but also silenced the expression of the
fibroblast-specific genes Fsp1 and Col1a1 (Figure 2G and
Figure S1C).
Electrophysiological Function of CiNs
To examine the electrophysiological properties of the CiNs, we
performed whole-cell patch-clamp recordings (Figure 3A). By
depolarizing the membrane in current-clamp mode, action po-
tentials (APs) were elicited on the CiNs with extending branches
(35.0%, n=20) after 14–20daysof chemical induction (Figure 3B;
Table S3). Furthermore, fast, inactivating inward and outward
currents were recorded on the CiNs in the voltage-clamp
mode, which may correspond to the opening of voltage-depen-
dent K+- and Na+-channels (Figure 3C; Table S3). Accordingly,
when the CiNs were re-plated onto a pre-existing monolayer cul-
ture of primary astrocytes or primary neurons, the functional
membrane properties of the CiNs were significantly enhancedC(53.8%, n = 39) (Figures 3D and 3E; Table S4), and spontaneous
excitatory postsynaptic currents (EPSCs) could also be recorded
(47.6%, n = 21) (Figure 3F and Figure S1D; Table S4). The EPSCs
could be blocked by the specific receptor antagonists 6-cyano-
7-nitroquinoxaline-2,3-dione (CNQX) and 2-amino-5-phospho-
novaleric acid (AP5) (Figure 3F). These results suggest that
the CiNs have functional membrane properties and that after
development by being co-cultured with primary astrocytes or
primary neurons the CiNs are capable of forming functional
synaptic connections with each other or with the pre-existing
primary neurons.
Lineage Tracing to Confirm the Fibroblast-to-Neuron
Chemical Reprogramming
To confirm the fibroblast origin of the initial cell culture, we em-
ployed a Cre-LoxP lineage tracing system to trace the fate of
original fibroblasts expressing a fibroblast-specific gene, Fsp1
(Bhowmick et al., 2004; Iwano et al., 2002; Madisen et al.,
2010; Strutz et al., 1995) (Figure S2A). TdTomato-positive cells
were further confirmed by being co-immunostained with another
fibroblast marker, COL1A1 (Figures S2B and S2C). After the
chemical induction, the tdTomato-positive cells developed
extensive branch outgrowth (Figure S2D). We found that tdTo-
mato-positive cells could be chemically reprogrammed into
neuronal cells with a comparatively high efficiency (Figures
S2E–S2Q). This result provides direct genetic proof of the chem-
ical reprogramming of fibroblasts into neurons.
CiN Generation Is Direct without an Intermediary
Proliferative Stage
To further understand the reprogramming process, we treated
the cells with 5-bromodeoxyuridine (BrdU) with the small-mole-
cule induction and throughout the culture period for chemical re-
programming (Figure S3A) (Vierbuchen et al., 2010). The results
showed that the vast majority (about 80%) of the TUJ1-positive
iNs did not incorporate BrdU (Figures S3B and S3C), indicating a
direct cell fate reprogramming bypassing an intermediary prolif-
erative stage.
Small Molecules Directly Induced Neuronal-Master
Transcription Factors and Disrupted the Fibroblast-
Specific Program during CiNs Generation
To explore the roles of the small molecules in chemical reprog-
ramming, we first investigated their biological activity by replac-
ing the individual small molecules with functional analogs.
We found that Forskolin (a cyclic AMP, or cAMP, agonist),
CHIR99021 (a glycogen synthase kinase 3 beta, or GSK3, inhib-
itor), and I-BET151 (a BET family bromodomain inhibitor) could
be substituted by other cAMP agonists, GSK3 inhibitors, and
BET inhibitors, respectively (Figure S1E), suggesting that these
activities correspond to their functional targets in chemical re-
programming of fibroblasts into CiNs.
To better understand the process of cell fate reprogramming,
we carried out RNA-seq analysis to examine the change of
global expression profiling after treating cells with small mole-
cules for 48 hr and 19 days. As demonstrated by hierarchical
clustering, the induced cells grouped closely to the primary neu-
rons but distinctly from the fibroblasts (Figure S4A). Based on se-
lection of genes differently expressed at least 3-fold amongell Stem Cell 17, 195–203, August 6, 2015 ª2015 Elsevier Inc. 197
(legend on next page)
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Figure 3. Electrophysiologically Functional
Properties of the CiNs
(A) Patch-clamp recordings were performed
14–20 days after chemical induction. Scale bars
represent 50 mm.
(B) Whole-cell current-clamp recording of CiNs.
APs were elicited by current injection. One
exemplary AP trace was highlighted.
(C) Whole-cell voltage-clamp recording of CiNs,
with inward and outward currents recorded.
(D and E) After co-culture with primary neurons,
the functional membrane properties of the CiNs
were significantly enhanced. One exemplary AP
trace was highlighted.
(F) Spontaneous EPSCs were recorded from CiNs
co-cultured with primary neurons and blocked by
20 mM CNQX and 50 mM AP5.fibroblasts, CiNs, and primary neurons (Caiazzo et al., 2011; Du
et al., 2014), the general degree of overlapping specifically ex-
pressed genes showed similarities between the induced cells
and the primary neurons (Figure S4B). Compared to the fibro-Figure 2. Efficiently Generating CiNs
(A) Diagram of the process to identify small molecule candidates that facilitate reprogramming.
(B) Quantification of TUJ1-positive cells, NEUN/TUJ1 double positive cells and TAUEGFP/TUJ1 double p
individual chemicals from FICSB.
(C) TUJ1-stained cells 14 days after treatment with the FICS or FICS+I-BET151.
(D) Representative TUJ1-, MAP2-, NF-H-, GABA-, and vGLUT1-positive induced cells. The bottom right panel
the bottom left panel.
(E) Mature TAUEGFP-positive CiNs expressed TUJ1 and NEUN 2 weeks after co-culture with primary neuro
(F) Diagram of generating CiNs.
(G) Single-cell analysis of the CiNs. FBs, fibroblasts; PNs, primary neurons.
Scale bars represent 100 mm (C and D, upper, middle, and lower left), 50 mm (E), and 20 mm (D, lower right).
Cell Stem Cell 17, 195–20blasts, the cells at 19 days post-treat-
ment enriched the expression of multiple
neuronal-specific genes, including genes
involving in neuronal morphogenesis
and maintenance, ion channels, and
functional synaptic components (Mapt,
Gap43, Stmn3, Stmn4, Syn1, Syp, and
Syt1) (Figures S4C and S4D). Further-
more, the expression of fibroblast hall-
mark genes (Fap, Des, Twist2, and
others) was downregulated (Figure S4D)
(Caiazzo et al., 2011; Kim et al., 2011),
indicating loss of the original fibroblast
features in CiNs. Consistently, by select-
ing genes that were >10-fold differentially
expressed for analysis, expression of the
fibroblast-enriched gene program was
disrupted in the small-molecule-treated
cells, while neuron-enriched genes were
upregulated (Figure 4A). After 19 days
of chemical induction, 60.6% of the
neuron-enriched genes were upregulated
by at least 2-fold, while only 1.8%
were downregulated. Furthermore, 80%
of the fibroblast-enriched genes were
also downregulated by at least 2-fold,whereas only 6.1%were upregulated, suggesting that the chem-
ical induction has the dual effect of activating global neuron-
enriched genes and suppressing global fibroblast-enriched
genes (Figure 4A). GO (Gene Ontology) analysis showed thatositive cells induced by FICSB or by withdrawing
is a higher magnification (23) of the area marked in
ns.
See also Figures S1 and S2.
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Figure 4. Roadmap of Chemical Reprog-
ramming
(A) Heatmap showing global expression change of
neuron-enriched genes and fibroblast-enriched
genes after 19-day induction by FICB.
(B and C) The activation of master neuronal genes
(B) and the suppression of fibroblast genes (C)
were validated by real-time qPCR.
(D) ISX9 was necessary to activate some neuronal
genes.
(E and F) The effect of individual chemicals on the
expression of Ngn2 and fibroblast genes at 48 hr.
(G) The effect of individual chemicals on global
gene expression. ‘‘Up-regulated’’ represents
genes whose expression level was upregulated by
more than 2-fold compared to fibroblasts, while
‘‘down-regulated’’ represents genes whose
expression level was downregulated by more than
2-fold compared to fibroblasts.
(H) Schematic representation of the roles of small
molecules in the process of CiN generation.
The data are presented as the mean ± SEM. See
also Figures S3 and S4.the upregulated genes after chemical induction were mainly
enriched in synaptic transmission, neuron differentiation, neuron
development, ion transport, axonogenesis, ion channel activ-
ities, and other crucial biological process in neural development
(Figure S4E). The downregulated genesmainly participate in bio-
logical processes such as the cell cycle, cell division, and others
(Figure S4E). Taken together, these results indicate that the cells,
by small-molecule induction, gained a transcriptional profile200 Cell Stem Cell 17, 195–203, August 6, 2015 ª2015 Elsevier Inc.resembling that of primary neurons and
disrupted the program of the original cells
from the single-cell and global experi-
mental perspectives.
By RT-qPCR analysis, we found that
the activation of the neural-fate-deter-
mining factors and the downregulation
of fibroblast-fate-determining factors
were induced within 24 hr (Figures 4B
and 4C). ISX9 is necessary to activate
multiple neuron-specific genes, including
the neural-fate mastering gene NeuroD1
(Figures 4D). During the first 48 hr of
chemical induction, the expression of
NeuroD1 and Ngn2, another neural-fate
mastering gene, was dramatically
induced (Figures 4B and 4E), suggesting
that these two transcription factors may
be involved in the first step of chemical
reprogramming. Interestingly, Ascl1, the
master transcription factor most fre-
quently used to induce neuronal fate con-
version, was not activated in the early
stage of reprogramming (Figure 4B).
Next, we determined the roles of the
small molecules in regulating these
endogenous cell-fate-determining fac-
tors. By removing each small moleculefrom the cocktail, we found that ISX9 was essential to induce
the master neural genes (Figures 4D–4F), suggesting that the
small-molecule cocktail induces the neural-fate-determining
program in an ISX9-dependent, synergistic manner. Interest-
ingly, we found that I-BET151 was the core small molecule
needed to suppress the endogenous fibroblast-fate-determining
program (Figures 4F and 4G), and it accounts for an efficient
disruption of the fibroblast core transcriptional network by
chemicals. These results indicated that cell fate was manipu-
lated by small molecules through synergistic activation of the
target cell fate regulatory program and repression of the original
cell fate program (Figure 4H).
DISCUSSION
In this study, we identified a cocktail of small molecules that
induces an efficient direct lineage reprogramming across germ
layers from fibroblasts into functional neurons. The CiNs
possess neuronal properties in terms of gene expression pattern
and electrophysiological functional capabilities. Taking together
the CiNs and the chemically induced pluripotent stem cells
(CiPSCs) (Hou et al., 2013), these findings demonstrate that so-
matic cell fates can be converted by the manipulation of cell
signaling pathways and endogenous cell-fate-determining
programs with only small molecules, without the need for exog-
enous transgenes or other cell-fate-specific factors such as
microRNAs.
Although master transcription factors are considered the ma-
jor determinants of specific cell identities (Xu et al., 2015), our
findings show that a small molecule cocktail is sufficient to acti-
vate the expression of such genes. As shown in our study, ISX9,
an isoxazole, which has been shown to facilitate neural differen-
tiation via a neurotransmitter-evoked Ca2+ signal (Schneider
et al., 2008), is necessary to induce the activation of neuronal
genes in fibroblasts, and this process was further enhanced by
other small molecules (Figures 4D and 4E). For induction of
CiNs, Ngn2 and NeuroD1 were the first-wave responsive genes
in the reprogramming process, and they were activated within
6 hr (Figure 4B). Recently, Ngn2, the neuron-fate-determining
proneural gene in development, has been demonstrated to be
capable of establishing neuronal cell fate with additional tran-
scriptional factors or small molecules (Bertrand et al., 2002; Liu
et al., 2013). Other neural factors were sequentially activated in
the following days (Figure 4A and Figure S4D). This staged
gene activation suggests that small-molecule-driven fibroblast-
to-neuron direct reprogramming is a hierarchical transcriptional
activation process, in which the efficient activation of cell-fate-
determining genes by small molecules may initiate and stabilize
an auto-regulatory loop of the neuronal-specific transcriptional
program and may further stimulate the expression of down-
stream regulatory genes to establish neuronal functional
properties.
Interestingly, the addition of I-BET151 into the small molecule
cocktail significantly improved the reprogramming process (Fig-
ures 2B and 2C), and we further found that I-BET151 was the key
small molecule for disruption of the fibroblast core transcrip-
tional network (Figure 4F). I-BET151 is reported to competitively
bind at the BRD domain of BET family proteins (Seal et al., 2012).
BRD4, a BET family protein, was reported to specifically bind
to the activated chromatin domains and maintain the cell-fate-
specific gene expression pattern (Wu et al., 2015). Inhibition of
BRD4 can disrupt cell fate maintenance and alter the gene
expression pattern of the initial cell type (Chiang, 2014; Di Micco
et al., 2014), consistent with our finding that I-BET151 directly
disrupts the fibroblast-specific gene expression program in early
stage reprogramming (Figures 4D and 4F). Moreover, our results
are also consistent with a ‘‘mutual repression model’’ of cell fateCconversion (Wang et al., 2011) and the previous finding that cell
fate reprogramming could be facilitated by knockdown of key
transcription factors in the initial cell type (Hanna et al., 2008).
Furthermore, it was found very recently that BRD4 binds to su-
per-enhancers of core genes to maintain the pluripotent cell
fate of ESCs, and inhibition of BRD4 results in loss of the core
program of ESCs and their commitment to a neuroectodermal
lineage (Di Micco et al., 2014). It is possible that small molecules
that are targeting protein complexes at super-enhancers or that
are related to active gene expression may contribute to cell line-
age reprogramming as a general eraser of initial cell identities in
the future.
Although the small molecules identified in our study are not
specific to the neural lineage, the pathways that they target
have been reported to be involved in directed neural differentia-
tion in vitro and even in neural development in vivo. CHIR99021 is
traditionally used to induce neuronal development from pluripo-
tent stem cells as a GSK3 inhibitor (Chambers et al., 2009), and it
has been reported as a chemical booster that enhances tran-
scription-factor-based neuronal conversion (Ladewig et al.,
2012). Forskolin is a diterpene adenylate cyclase activator and
is commonly used to increase the level of cyclic AMP (cAMP)
(Seamon et al., 1981), and cAMP-responsive element binding
(CREB), a downstream target of Forskolin, has been reported
to regulate neuronal specification and promote axonal regener-
ation (Seamon et al., 1981; Dworkin and Mantamadiotis, 2010).
The dual functions of these small molecules in direct differentia-
tion and lineage reprogramming suggest that developmental
cues and development-relevant signaling pathways could be
instructive in developing small molecule combinations that facil-
itate cell lineage reprogramming.
Overall, our study suggests a blueprint for engineering cell
identity using chemical agents in regenerative medicine. The
development of CiNs and CiPSCs (Hou et al., 2013) together
suggests a general strategy for developing small molecule cock-
tails that can manipulate cell fates by replacing reported lineage
reprogramming genes, activating desirable cell-type-specific
master gene expression, and silencing initial cell-type-specific
master gene expression. To move toward therapeutic ap-
proaches, we anticipate that it will be possible to employ this
type of chemical reprogramming strategy to manipulate human
somatic cell fates. In the future, it may well be possible to identify
other small molecule cocktails capable of inducing other func-
tional cell types by direct lineage reprogramming and to define
more precisely the mechanistic elements underlying cell fate
maintenance and reprogramming. Our findings also may sug-
gest an unanticipated level of somatic cell plasticity and indicate
that somatic cell identity is much more flexible than previously
appreciated.EXPERIMENTAL PROCEDURES
Generation of CiNs
Small molecules (from Tocris) (Table S1B) were dissolved and diluted in DMSO
according to the manufacturer’s instructions and then processed to use at the
following final concentrations: ISX9, 20 mM; SB431542, 10 mM; Forskolin,
100 mM; CHIR99021, 20 mM; and I-BET151, 0.5–2 mM. The passaged fibro-
blasts were seeded onto a Matrigel-coated plate (BD; 1:30 in pre-cold PBS)
and were not chemically induced until confluent (preferentially seeded at a
density of 100,000 cells per well of a 6-well plate and induced after 4 days’ell Stem Cell 17, 195–203, August 6, 2015 ª2015 Elsevier Inc. 201
culture). The neuronal induction medium contained Neurobasal Medium, N2
and B27 supplements, GlutaMAX, penicillin-streptomycin (all from Life tech-
nologies), and bFGF (100–250 ng/ml; Origene). Culture medium (neuronal
induction medium plus the small molecules) was refreshed every 3–4 days
during the chemical induction period. For the proliferation assay, BrdU was
added at a final concentration of 10 mM and refreshed in medium. Note: cell
death was found in some fibroblast batches for inducing neurons (mainly
due to the toxicity and high dose of I-BET151). To enhance the survival rate
and facilitate reprogramming in these batches, ROCK inhibitor Y27632
(2 mM) or Fasudil (2 mM) can be used at the early stage of induction (from
day 0 to day 4–8), or P38 MAPK inhibitors SB203580 (1 mM) or BIRB796
(1 mM) can be used. After chemical treatment for 20 days, induction medium
was changed to maturation medium (the neuronal induction medium plus
Forskolin, 10 mM; BDNF, 20 ng/ml; and GDNF, 20 ng/ml). The cells were disso-
ciated by using 0.25% trypsin (note: gently dissociate within 1 min to reduce
the damage to the induced neuron-like cells) or mechanistically detached by
pipette (note: gently handle to reduce the damage to the induced neuron-
like cells) from the culture plate, and then re-plated to co-culture with primary
astrocytes/pre-existing primary neurons (preferentially cultured 7 days) at day
21–35 for further maturation. (Note: see also Supplemental Experimental Pro-
cedures.) Animal experiments were approved and performed according to the
Animal Protection Guidelines of Peking University, China.
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